- Companies
- Angle Health
Angle Health Valuation, Funding & Investors
Angle Health is valued at $2.7B as of September 2026.
Last Angle Health valuation
$2.7B
Series C · Sep 2026
Last Angle Health funding round
$200M
Series C · Sep 2026
Cumulative funding Angle Health raised
$396M
across 4 funding rounds
Key investors in Angle Health
Y Combinator
Blumberg Capital
Portage Ventures
TSVC
PruVen Capital
Correlation Ventures
About Angle Health
Angle Health is a New York-based provider of health insurance platforms and self-funded plans for startups. The company offers customizable medical benefits administration, pharmacy benefits, and virtual care integrations for employers with 10 to 500 employees.
Founded
2019
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Valuation
$2.7B (Sep 2026)
Angle Health Valuation
Angle Health is currently valued at $2.7B, based on its Series C in September 2026.
The $200M round was led by Vitruvian Partners, with participation from Blumberg Capital, Y Combinator, Town Hall Ventures, Portage Ventures and PruVen Capital.
Angle Health's valuation has grown 169x from $16M at its seed round in July 2020 to $2.7B in September 2026, across 3 priced rounds.
Angle Health valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Sep 2026 | Series C | $2.7B |
| Sep 2026 | Secondary | $2.7B |
| Jul 2020 | Seed | $16M |
Angle Health Funding History
Angle Health has raised a total of $396M across 4 funding rounds, plus 1 secondary share sale.
Angle Health's first fundraising round was a $4M seed round in July 2020. The most recent completed round was a $200M Series C in September 2026.
Angle Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Sep 2026 | Series C | Vitruvian Partners (lead); Blumberg Capital; Y Combinator; Town Hall Ventures; Portage Ventures; PruVen Capital | $200M | $2.7B | Angle Health announced a $600 million equity financing at a $2.7 billion valuation, structured as a $200 million Series C primary financing plus a $400 million tender offer for existing shares. The round was led by Vitruvian Partners, with participation from new investor Town Hall Ventures and existing investors Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator, and was announced in September 2026 with closing expected later that month. The transaction was positioned to support expansion of the company’s AI-native healthcare benefits platform for small and midsize businesses, with the primary capital directed toward scaling operations, product development, and market expansion while the tender offer provided liquidity to early shareholders and employees. Angle Health was founded by former Palantir engineers and sells software and services used to build, manage, and administer health plans for employers. The company describes itself as an AI-native healthcare benefits platform and operates in the employer health benefits and insurtech market, serving small businesses and midsize employers. The announced financing brought together a mix of new and existing venture backers and combined growth capital with secondary liquidity in a single transaction. |
| Sep 2026 | Secondary | - | $400M | $2.7B | Angle Health announced a $600 million equity financing at a $2.7 billion valuation in September 2026, structured as a $200 million Series C primary investment led by Vitruvian Partners together with a $400 million tender offer providing liquidity to early investors and employees. The transaction was expected to close later that month, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The financing was positioned to support Angle Health’s expansion as an AI-native healthcare benefits platform serving small and midsize businesses, while also delivering secondary liquidity to existing shareholders. The company had been founded by former Palantir engineers Ty Wang and Anirban Gangopadhyay and had previously backed by Y Combinator and other venture investors. Angle Health provides employer health plans and benefits infrastructure, with the business framed around using software and AI to simplify benefits administration and improve plan access for SMBs. The company described the deal as a combination of fresh capital and shareholder liquidity rather than an acquisition or SPAC transaction. |
| Dec 2025 | Series B | Portage Ventures (lead); Blumberg Capital; Mighty Capital; Y Combinator; SixThirty; PruVen Capital; TSVC; Wing Venture Capital | $134M | - | Angle Health, an AI-native healthcare benefits platform, raised $134 million in a Series B round led by Portage Ventures in December 2025, with participation from Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC, and Y Combinator. The round was oversubscribed and included a mix of debt and equity, bringing total company funding to approximately $200 million since inception. The company serves over 2,600 to 3,000 small and mid-sized business employers across 44 states, offering an integrated platform that combines healthcare benefits administration, plan customization, care navigation, and digital health services including telemedicine and behavioral health. Angle Health employs AI and machine learning to streamline quoting, underwriting, and administrative processes while providing transparency and cost efficiency to employers struggling with healthcare expenses. The company has demonstrated strong unit economics with customer renewal rates exceeding 80% and member satisfaction at 90%, and has grown revenue 26x since its Series A round. With this funding, Angle Health plans to expand access to its platform across more states and scale delivery-side services to provide members with higher-quality, more cost-effective treatment options while building out additional financial and healthcare services. |
| Jan 2023 | Series A | Portage Ventures (lead); Blumberg Capital; Mighty Capital; Mindset Ventures; Y Combinator; Waseem Daher; Wormhole Capital; SixThirty; PruVen Capital; TSVC; Correlation Ventures; Aloft VC; Wing Venture Capital | $58M | - | Angle Health is a San Francisco-based digital-first, fully-licensed health insurance provider offering an AI-powered platform for customizable health benefits targeted at small and mid-sized businesses, employers, brokers, and members. Founded in 2020 by former Palantir engineers Ty Wang and Anirban Gangopadhyay after participating in Y Combinator's Winter 2020 cohort, the company provides transparency, simplicity, and frictionless experiences in an industry known for rigid plans and opaque underwriting. On January 25, 2023, Angle Health announced a $58 million Series A funding round (noted as Series A-II in some sources) led by Portage Ventures, with participation from PruVen Capital, Wing Venture Capital, SixThirty Ventures, Mighty Capital, Wormhole Capital, Mindset Ventures, Crew Capital, Aloft VC, Pilot founder Waseem Daher, and support from existing investors Blumberg Capital, Correlation Ventures, TSVC, and Y Combinator. This followed a seed round in summer 2020 and an earlier Series A in December 2022, bringing prior total funding context into the expansion phase. The new capital supported geographic expansion into Arizona, Georgia, Indiana, Ohio, Missouri, and South Carolina, alongside development of its AI-native technology for risk identification, plan structuring, and tools like Benefit Builder for rapid custom quotes. The January 2023 round aligned with Angle Health's growth strategy amid rising healthcare costs, positioning it to modernize employer-sponsored coverage through proprietary AI models trained on de-identified patient data, incorporating medical, pharmacy, claims, and population health metrics for predictable costs and personalized interventions. Portage highlighted Angle's innovation akin to Kin and Lemonade in personal insurance, emphasizing convenience, affordability, and a rebuild of operational infrastructure in financial services-adjacent healthcare. Angle operates in the $4 trillion U.S. health insurance market facing ACA premium hikes over 15%, regulatory scrutiny on payers like UnitedHealth and Centene, and employer expense surges projected as the largest in 15 years. Its platform delivers 36% median rate increase reductions versus market benchmarks, stronger broker close rates, and tools like Health Scorecard for visibility. Later 2025 updates note 26x revenue growth since the 2022/2023 Series A period, over 80% renewal rates, 90% member satisfaction, and service to 3,000+ employers in 44 states. Subsequent developments include a December 2025 $134M oversubscribed Series B (mix of equity/debt) led by Portage with Blumberg Capital and others, scaling total funding to nearly $200M, underscoring traction in HealthTech for SMB benefits disruption. |
| Jul 2020 | Seed | Blumberg Capital (lead); Y Combinator; Liquid 2 Ventures; Luca Ventures; TSVC; Nate Matherson; Correlation Ventures | $4M | $16M | Angle Health is a health insurance startup offering tech-enabled health plans for startups and small businesses, focusing on mobile-first benefits including primary care, urgent care, mental health, chronic disease management, and reproductive health. The company integrates with HR platforms for streamlined enrollment and billing and aims to be ACA-compliant, covering essential health benefits. On July 21, 2020, Angle Health closed a $4 million Series Seed funding round led by Blumberg Capital, with participation from Y Combinator, Correlation Ventures, TSVC, Liquid 2 Ventures, and angels. The post-money valuation was $15.67 million. Proceeds support regulatory filings, mobile app launch, and infrastructure for expanded medical services accessibility. Blumberg Capital highlighted Angle Health's appeal due to its focus on the underserved startup demographic, attractive unit economics, and potential in a market driven by telemedicine and virtual healthcare innovations. |
Who has invested in Angle Health?
18 investors have backed Angle Health across its funding rounds, including Y Combinator, Blumberg Capital, Portage Ventures, TSVC, PruVen Capital and Correlation Ventures.
Lead investors include Vitruvian Partners, Portage Ventures and Blumberg Capital.
Angle Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Lead | Jul 2020 | ||
| 4 | Participant | Jul 2020 | ||
| 3 | Lead | Jan 2023 | ||
| 3 | Participant | Jan 2023 | ||
| 3 | Participant | Jul 2020 | ||
| 2 | Participant | Jan 2023 | ||
| 2 | Participant | Jan 2023 | ||
| 2 | Participant | Jul 2020 | ||
| 2 | Participant | Jan 2023 | ||
| 1 | Participant | Jan 2023 | ||
| 1 | Participant | Sep 2026 | ||
| 1 | Participant | Jul 2020 | ||
| 1 | Participant | Jan 2023 | ||
This data is available for Pro users. Sign up to see all 18 Angle Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAngle Health Competitors
Angle Health competitors include listed companies like Clover Health, AIX Inc., eHealth and Rasan, and private ones like bolttech and Kin Insurance.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $1.9B | ($84M) | $2.3B | 0.8x | ||
| Publicly listed | $84M | ($345M) | $501M | - | ||
| Publicly listed | $554M | $83M | $16M | 1.0x | ||
| Publicly listed | $174M | $73M | $2.8B | 9.3x | ||
| Private | - | - | $2.1B | - | ||
| Private | $202M | - | $2B | 10.1x |
Angle Health Public Comps
Angle Health is still privately-owned, but its public comps include Pluxee, Ethos Insurance, Rasan, Clover Health, Progyny, Lemonade, Slide Insurance Holdings, ZhongAn, Exzeo Group and Trupanion.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1.5B | $508M | 0.9x | 0.9x | 2.5x | 2.4x | |||
| $388M | $79M | 6.8x | 3.8x | 33.4x | 22.2x | |||
| $174M | $73M | 14.6x | 9.3x | 35.1x | 21.9x | |||
| $1.9B | ($84M) | 1.1x | 0.8x | (25.3x) | 30.2x | |||
| $1.3B | $90M | 1.6x | 1.5x | 22.4x | 8.6x | |||
| $738M | ($146M) | 4.5x | 2.9x | (22.9x) | (57.6x) | |||
| $1.2B | $605M | 2.2x | 1.5x | 4.3x | 4.1x | |||
| $5.2B | $320M | 0.5x | 0.5x | 8.8x | 17.7x | |||
This data is available for Pro users. Sign up to see all Angle Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Angle Health
| When was Angle Health founded? | Angle Health was founded in 2019. |
| Where is Angle Health headquartered? | Angle Health is headquartered in San Francisco, CA, United States. |
| Is Angle Health publicly listed? | No, Angle Health is a private, VC-backed company. |
| What is Angle Health's valuation? | Angle Health was last valued at $2.7B in its Series C in September 2026. |
| How much funding has Angle Health raised? | Angle Health has raised $396M across 4 funding rounds. |
| What was Angle Health's last funding round? | Angle Health's last funding round was a $200M Series C in September 2026, led by Vitruvian Partners. |
| Who are Angle Health's investors? | Angle Health's investors include Blumberg Capital, Y Combinator, Portage Ventures, PruVen Capital, TSVC, Mighty Capital, SixThirty, Correlation Ventures, Wing Venture Capital, Mindset Ventures and 8 others. |
| Which companies are comparable to Angle Health? | Companies comparable to Angle Health include Clover Health, AIX Inc., eHealth, Rasan, bolttech and Kin Insurance. |
See companies similar to Angle Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




